megestrol has been researched along with Breast Cancer in 144 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (45.83) | 18.7374 |
| 1990's | 62 (43.06) | 18.2507 |
| 2000's | 11 (7.64) | 29.6817 |
| 2010's | 5 (3.47) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
| Berretta, M; Cavaliere, C; Del Pup, L; Di Francia, R; Di Napoli, M; Facchini, G; Fiorica, F; Mileto, M; Schindler, AE | 1 |
| Lello, S | 1 |
| DeMichele, A; Gogineni, K | 1 |
| Cahill, MA; Chen, R; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Schultz, S; Seeger, H; Yu, Q | 1 |
| Rocchi, A; Verma, S | 1 |
| Shields-Botella, J | 1 |
| Caruggi, M; Colombo, G; Marchetti, M | 1 |
| Chetrite, G; Meschi, S; Pasqualini, JR; Shields-Botella, J | 1 |
| Benedict, A; Brown, RE | 1 |
| Blumenschein, GR; Buzdar, AU; Ross, MB | 1 |
| Alexieva-Figusch, J; Blonk-van der Wijst, J; Hop, WC; Teulings, FA; van Gilse, HA | 1 |
| Blumenschein, GR | 1 |
| Kauppila, A | 1 |
| Anderson, K; Bonomi, P; Fischer, W; Mitsuyasu, R | 1 |
| Canetta, R; Florentine, S; Hunter, H; Lenaz, L | 1 |
| Adlercreutz, H; Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Docter, R; Hop, WC; Klijn, JG; Lamberts, SW; van Gilse, HA | 1 |
| Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW | 1 |
| Klijn, JG | 1 |
| Long, HJ; Otteman, LA | 1 |
| Greenwald, ES | 1 |
| De-Wei, Z | 1 |
| Ahmann, DL; Creagan, ET; Edmonson, JH; Green, SJ; Hahn, RG; Ingle, JN; Rubin, J | 1 |
| Ansfield, FJ; Kallas, GJ; Singson, JP | 1 |
| Smibert, J | 1 |
| Alexieva-Figusch, J; Blonk-van der Wijst, J; Hop, WC; Phoa, CH; Treurniet, RE; van Gilse, HA | 1 |
| Catherino, WH; Jordan, VC | 1 |
| Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D | 1 |
| Dahrouge, S; Stewart, DJ | 1 |
| Blacker, C; Botella, J; Chetrite, G; Delalonde, L; Feinstein, MC; Maloche, C; Nguyen, BL; Paris, J; Pasqualini, JR; Talbi, M | 1 |
| Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
| Amoroso, D; Balestrero, M; Boccardo, F; Brema, F; Cellerino, R; Farris, A; Folco, U; Iacobelli, S; Mesiti, M; Miglietta, L | 1 |
| Fletcher, WS; Pommier, RF; Woltering, EA | 1 |
| Harrison-Woolrych, M; Robinson, R | 1 |
| Beerman, H; Bontenbal, M; Logmans, A; Mous, HV; van Lent, M | 1 |
| Blamey, RW; Cannon, P; Ellis, IO; Gee, JM; Manning, DL; McClelland, RA; Nicholson, RI; Robertson, JF | 1 |
| Hill, LM; Lazebnik, N; Robinson, TM | 1 |
| Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R | 1 |
| Crawford, DJ; George, WD; Leake, RE; Paul, J; Smith, DC; Stewart, M | 1 |
| Espie, M | 1 |
| Dose, AM; Fischer, T; Hatfield, AK; Johnson, C; Klatt, NE; Loprinzi, CL; Michalak, JC; Nelimark, RA; O'Fallon, JR; Quella, SK | 1 |
| Botella, J; Cognet, AM; Delansorne, R; Duc, I; Duranti, E; Paris, J | 1 |
| Beinfield, M; Fischer, D; Haffty, BG; McKhann, C; Wilmarth, L; Wilson, L | 1 |
| Casazza, AM; Horwitz, SB; Trail, PA; Wang, L; Yang, CP | 1 |
| Abrams, J; Aisner, J; Canellos, GP; Cooper, MR; Herndon, JE; Hollis, DR; Kornblith, AB; Lyss, AP; Phillips, CA; Zuckerman, E | 1 |
| Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R | 1 |
| Cobau, CD; Declercq, K; Ingle, JN; Neuberg, D; Tormey, DC | 1 |
| Bonomi, P; Buzdar, AU; Cooper, J; Favis, G; Keller, AM; Mulagha, M; Smith, R; Vogel, C | 1 |
| Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH | 1 |
| Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F | 1 |
| Azab, M; Blomqvist, C; Eiermann, W; Hellmund, R; Howell, A; Jonat, W; Lundgren, S; Mauriac, L; Roche, H; Tyrrell, C; Winblad, G | 1 |
| Botella, J; Chetrite, G; Paris, J; Pasqualini, JR | 1 |
| Helle, SI; Lønning, PE | 1 |
| Budd, GT; Congdon, JE; Green, SJ; Hynes, HE; Martino, S; O'Sullivan, J; Osborne, CK; Russell, CA | 1 |
| Blomqvist, CP; Buzdar, AU; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Lee, D; Steinberg, M; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V | 1 |
| Costello, S; Glück, S; Heffernan, M; Hortobagyi, GN; Kennedy, I; Knight, RD; Leff, R; Lipton, A; Mellars, K; Reitsma, DJ; Seaman, JJ; Simeone, J; Stewart, JF; Theriault, RL | 1 |
| Cattel, F; Messori, A; Trippoli, S; Vaiani, M | 1 |
| Hillner, BE; Radice, D | 1 |
| Chen, Y; Guo, WJ; He, KL; Li, J; Xia, P; Xu, LZ; Zheng, YH | 1 |
| Jönsson, B; Lindgren, P; Radice, D; Redaelli, A | 1 |
| Guo, W; He, K; Li, J; Xia, P; Xu, L; Zheng, Y; Zhu, X | 1 |
| Dow, KH | 1 |
| Briggs, MH; Owen, LN | 1 |
| Brennan, MJ | 1 |
| Blumenschein, GR; Bodey, GP; Buzdar, AU; Hortobagyi, GN; Krutchik, AN; Livingston, RB; Tashima, CK; Yap, HY | 1 |
| Ansfield, FJ; Borden, EC; Bryan, GT; Davis, HL; Davis, TE; Johnson, RO; Ramirez, G | 1 |
| Cruz, JM; Muss, HB | 1 |
| Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Rosen, D; Shapira, J | 1 |
| Abrams, JS; Aisner, J; Gutheil, J | 1 |
| Cruz, JM; Muss, HB; Russell, G | 1 |
| Lundgren, S | 1 |
| Blamey, RW; Chan, S; Dixon, AR; Haybittle, J; Jackson, L | 1 |
| Kvinnsland, S; Lien, EA; Lundgren, S; Lønning, PE | 1 |
| Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
| Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
| Abrams, JS; Aisner, J; Parnes, HL; Tait, N; Tchekmedyian, NS | 1 |
| Stoll, BA | 1 |
| Daniel, F; Rao, DG; Tyrrell, CJ | 1 |
| Brenner, BG; Margolese, RG | 1 |
| Amoroso, D; Bertelli, G; Brema, F; Conte, PF; Martini, MC; Pastorino, G; Pronzato, P; Rosso, R | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
| Sleijfer, DT; Tjabbes, T; van der Ploeg, E; van Veelen, H; Willemse, PH | 1 |
| Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Lundgren, S; Lønning, PE | 1 |
| Aisner, J; Greco, A; Hickman, M; Siau, J; Tchekmedyian, NS | 1 |
| de Ruyter-Buitenhuis, AW; Dikkeschei, LD; Nagel, GT; Sleijfer, DT; van der Slik, W; Willemse, PH; Wolthers, BG | 1 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, LP; Smaldone, L | 1 |
| Abrams, JS; Aisner, J; Parnes, H | 1 |
| Alexieva-Figusch, J; Stoter, G; van der Gaast, A; Vecht, C; Verweij, J | 1 |
| Capizzi, RL; Case, LD; Cooper, MR; Cruz, J; Jackson, D; Muss, HB; Powell, BL; Richards, F; Spurr, CL; White, D | 1 |
| Aakvaag, A; Kvinnsland, S; Lundgren, S; Lønning, PE | 1 |
| Anderson, S; Sigal, RB; Smalley, RV | 1 |
| Dahrouge, S; Fine, S; Hanson, J; McDermot, RS; Paterson, AH; Pritchard, KI; Sansregret, E; Stewart, DJ; Trudeau, M; White, DF | 1 |
| Brockschmidt, JK; Cruz, JM; Evans, GW; Muss, HB | 1 |
| Aakvaag, A; Kvinnsland, S; Lundgren, S; Lønning, PE; Utaaker, E | 1 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
| Kvinnsland, S; Lundgren, S; Utaaker, E | 1 |
| Johnson, PA; McGuire, WL; Muss, HB; Osborne, CK | 1 |
| Gerner, EW | 1 |
| Gundersen, S; Klepp, R; Kvinnsland, S; Lund, E; Lundgren, S; Lønning, PE | 1 |
| Blamey, RW; Morgan, DA; Nicholson, RI; Robertson, JF; Todd, J; Williams, MR | 1 |
| Mackintosh, JF | 1 |
| Carpenter, JT | 1 |
| Foitl, DR; Hyman, G; Lefkowitch, JH | 1 |
| Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D | 1 |
| Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E | 1 |
| Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE | 1 |
| Becher, R; Miller, AA; Schmidt, CG | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Blossey, HC; Emrich, D; Nagel, GA; Wander, HE | 1 |
| Glick, JH; Haller, DG | 1 |
| Allegra, J; Bertino, JR; Bonomi, P; Browder, H; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Ettinger, DS | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Twining, P; Williams, MR | 1 |
| Sedlacek, SM | 1 |
| Aisner, J; Novak, M; Parnes, H; Tait, N; Tchekmedyian, NS | 1 |
| Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB | 1 |
| Anderson, K; Bonomi, P; Economou, S; Gale, M; Johnson, P; Von Roenn, J; Wolter, J | 1 |
| Black, W; Bonomi, P; Cooper, M; Johnson, PA; Muss, H; Paschold, E; Von Roenn, J; Wolter, J | 1 |
| Anderson, KM; Bonomi, PD; Economou, SG; Gale, M; Von Roenn, JH; Wolter, JM | 1 |
| Abrams, J; Aisner, J; Tait, N; Tchekmedyian, NS | 1 |
| Alexieva-Figusch, J; Schrijver, J; van Breederode, N; van Gilse, HA | 1 |
| Gale, KE; Hahn, RG; Horton, J; Keller, AM; Knuiman, M; Rosenbluth, RJ; Tormey, DC; Vogel, H | 1 |
| Aisner, J; Moody, M; Tait, N; Tchekmedyian, NS | 2 |
| Allegra, JC | 1 |
| Aisner, J; Tait, N; Tchekmedyian, NS | 1 |
| Anderson, KM; Bonomi, PD; Economou, SG; Johnson, PA; Wolter, JM | 1 |
| Aisner, J; Greco, FA; Moody, M; Tait, N; Tchekmedyian, NS | 1 |
| Cohen, SC; Gregory, EJ; Mims, CH; Oines, DW | 1 |
| Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Richards, F; Stuart, JJ | 1 |
| Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L | 1 |
| Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
| Benghiat, A; Cassidy, SA; Davidson, HE; Mancero, FS; Pickard, JG; Tyrrell, CJ | 1 |
| Allegra, JC; Kiefer, SM | 1 |
| Carpenter, JT; Peterson, L | 1 |
| Morgan, LR | 1 |
| Anderson, K; Bonomi, P; Bunting, N; Economou, S; Johnson, P; Roseman, D; Shorey, W; Strauss, A; Wolter, J | 1 |
| Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL | 1 |
| Ansfield, FJ; Davis, HL; Ellerby, RA; Ramirez, G | 1 |
23 review(s) available for megestrol and Breast Cancer
| Article | Year |
|---|---|
Nomegestrol acetate/estradiol hormonal oral contraceptive and breast cancer risk.
Topics: Breast; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Hormonal; Estradiol; Female; Humans; Megestrol; Membrane Proteins; Neoplasms, Hormone-Dependent; Norpregnadienes; Receptors, Progesterone; Risk | 2014 |
Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.
Topics: Animals; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Female; Hormone Replacement Therapy; Humans; Megestrol; Norpregnadienes; Progesterone Congeners; Risk Assessment; Risk Factors; Thromboembolism; Treatment Outcome | 2010 |
Current approaches to the management of Her2-negative metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Deoxycytidine; Doxorubicin; Estradiol; Female; Fulvestrant; Gemcitabine; Humans; Megestrol; Ovary; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; TOR Serine-Threonine Kinases | 2012 |
Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Aromatase; Biotransformation; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogens; Estrone; Female; Humans; Megestrol; Neoplasms, Hormone-Dependent; Norpregnadienes; Progesterone Congeners; Progestins; Sulfatases; Sulfotransferases | 2005 |
Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Decision Making; Female; Health Care Rationing; Health Expenditures; Humans; Megestrol; Models, Economic; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen | 2005 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
Megestrol acetate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms | 1983 |
Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Dilatation and Curettage; Female; Humans; Megestrol; Middle Aged; Postmenopause; Retrospective Studies; Tamoxifen; Treatment Outcome; Uterine Hemorrhage | 1994 |
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant | 1995 |
Insulin-like growth factors in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Endopeptidases; Estrogen Antagonists; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Megestrol; Neoplasms, Hormone-Dependent; Receptors, Somatomedin; Somatomedins; Tamoxifen; Tumor Cells, Cultured | 1996 |
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1998 |
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol; Neoplasm Metastasis; Nitriles; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2000 |
Existing and emerging endocrine therapies for breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Down-Regulation; Estrogen Receptor Modulators; Female; Humans; Megestrol; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Survival Rate; Tamoxifen | 2002 |
Endocrinology in cancer of the breast. Status and prospects.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenalectomy; Androgens; Animals; Breast Neoplasms; Carcinogens; Castration; Cyclic AMP; Cytosol; Estradiol; Estrogens; Female; Humans; Hypophysectomy; Mammary Neoplasms, Experimental; Megestrol; Mice; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Rats; Receptors, Cell Surface; Transplantation, Homologous | 1975 |
High-dose progestin therapy for metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Neoplasm Metastasis | 1992 |
Progestins in breast cancer treatment. A review.
Topics: Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrogens; Female; Growth Substances; Humans; Medroxyprogesterone; Megestrol; Menopause | 1992 |
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.
Topics: Aromatase Inhibitors; Biological Availability; Breast Neoplasms; Estrogen Antagonists; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Megestrol; Progesterone Congeners; Tissue Distribution | 1992 |
Overview of hormonal therapy in advanced breast cancer.
Topics: Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Meta-Analysis as Topic; Tamoxifen | 1990 |
Current status of high-dose progestins in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progesterone Congeners | 1990 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
An overview of megestrol acetate for the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Megestrol; Megestrol Acetate; Menopause; National Institutes of Health (U.S.); Tamoxifen; United States | 1988 |
Studies of high-dose megestrol acetate: potential applications in cachexia.
Topics: Body Weight; Breast Neoplasms; Cachexia; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate | 1988 |
42 trial(s) available for megestrol and Breast Cancer
| Article | Year |
|---|---|
Steroid receptors in megestrol acetate therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Laboratory Techniques; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Palliative Care; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid | 1984 |
Megestrol acetate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms | 1983 |
Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
Topics: Administration, Oral; Aged; Blood Glucose; Breast Neoplasms; Cortodoxone; Drug Administration Schedule; Estradiol; Female; Humans; Insulin; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin | 1984 |
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer.
Topics: Adult; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Humans; Megestrol; Menopause; Middle Aged; Prognosis; Random Allocation; Tamoxifen | 1982 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Interferon alpha-2; Interferon-alpha; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Recombinant Proteins | 1995 |
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Goserelin; Humans; Ki-67 Antigen; Megestrol; Megestrol Acetate; Menopause; Neoplasm Proteins; Nuclear Proteins; Postmenopause; Premenopause; Prognosis; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Tamoxifen; Treatment Outcome | 1994 |
Megestrol acetate for the prevention of hot flashes.
Topics: Breast Neoplasms; Climacteric; Double-Blind Method; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1994 |
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Retrospective Studies; Tamoxifen | 1994 |
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.
Topics: Appetite; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Megestrol; Megestrol Acetate; Middle Aged; Multivariate Analysis; Quality of Life; Treatment Outcome; Weight Gain | 1993 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen | 1993 |
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Survival Rate | 1996 |
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Double-Blind Method; Fadrozole; Female; Humans; Megestrol; Menopause; Middle Aged; Prognosis; Prospective Studies; Survival Analysis | 1996 |
Serial serum c-erbB-2 levels in patients with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome | 1996 |
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles | 1996 |
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Quality of Life; Remission Induction; Survival Rate; Triazoles | 1996 |
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Hydrocortisone; Megestrol; Middle Aged; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 1997 |
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Megestrol; Nitriles; Postmenopause; Proportional Hazards Models; Survival Rate; Triazoles | 1998 |
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Megestrol; Middle Aged; Neoplasm Metastasis; Pamidronate; Tamoxifen | 1999 |
Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma.
Topics: Androstadienes; Antineoplastic Agents; Breast Neoplasms; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Humans; Megestrol | 2001 |
Potential applications of high-dose megestrol acetate in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged | 1992 |
High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis | 1992 |
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
Topics: Breast Neoplasms; Drug Resistance; Female; Humans; Megestrol; Megestrol Acetate; Mitoxantrone; Neoplasm Staging; Probability; Prospective Studies; Receptors, Estrogen; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1991 |
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Topics: Body Weight; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Menopause | 1990 |
A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Adrenal steroids as parameters of the bioavailability of MA and MPA.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1990 |
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin | 1990 |
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Weight Gain | 1990 |
Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program.
Topics: Breast Neoplasms; Humans; Megestrol; Megestrol Acetate | 1990 |
Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Topics: Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1990 |
Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Topics: Blood Pressure; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Weight Gain | 1990 |
Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation | 1987 |
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Receptors, Cell Surface; Testosterone | 1985 |
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Random Allocation; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1986 |
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen | 1988 |
Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1987 |
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Tamoxifen | 1985 |
Metastatic breast cancer: preliminary results with oral hormonal therapy.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1985 |
LHRH-agonist treatment in clinical and experimental human breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen | 1985 |
80 other study(ies) available for megestrol and Breast Cancer
| Article | Year |
|---|---|
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |
Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells.
Topics: Breast; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Hormonal; Female; Humans; MCF-7 Cells; Megestrol; Membrane Proteins; Norpregnadienes; Receptors, Progesterone; Steroids | 2012 |
Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol; Middle Aged; Nitriles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2003 |
Nomegestrol acetate: a progestin that deserves recognition.
Topics: Breast Neoplasms; Cell Line, Tumor; Humans; Megestrol; Norpregnadienes; Progesterone Congeners | 2004 |
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Budgets; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Female; Humans; Italy; Letrozole; Markov Chains; Megestrol; Models, Economic; National Health Programs; Nitriles; Postmenopause; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2004 |
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen | 1982 |
The role of progestins in the treatment of breast cancer.
Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
Response to megestrol in male breast carcinoma.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Castration; Humans; Lung Neoplasms; Male; Megestrol; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone | 1984 |
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments.
Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1984 |
Hypercalcemic flare with megestrol acetate.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Hypercalcemia; Megestrol | 1984 |
Megestrol acetate flare.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Pain | 1983 |
Research activities in the field of oral contraceptives in the People's Republic of China.
Topics: Abnormalities, Drug-Induced; Breast Neoplasms; China; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Delayed-Action Preparations; Female; Genital Neoplasms, Female; Humans; Megestrol; Norethindrone; Research | 1982 |
Clinical results with megestrol acetate in patients with advanced carcinoma of the breast.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged | 1982 |
Hounding the pill.
Topics: Animals; Australia; Breast Neoplasms; Dogs; Drug and Narcotic Control; Female; Humans; Mammary Neoplasms, Experimental; Megestrol | 1980 |
Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.
Topics: Age Factors; Aged; Body Weight; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Lung Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Progesterone Congeners; Remission, Spontaneous; Retrospective Studies; Soft Tissue Neoplasms | 1980 |
Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.
Topics: Animals; Base Sequence; Binding Sites; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Estradiol Congeners; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Luciferases; Megestrol; Molecular Sequence Data; Norpregnadienes; Oligodeoxyribonucleotides; Progesterone Congeners; Recombinant Proteins; Structure-Activity Relationship; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vitellogenins; Xenopus | 1995 |
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Response of brain metastases from breast cancer to megestrol acetate: a case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local | 1995 |
Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Estrogens; Estrone; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Megestrol; Placenta; Progesterone; RNA, Messenger; Sulfatases; Tumor Cells, Cultured | 1995 |
Changes in serum sex steroid levels during megestrol acetate therapy.
Topics: Adrenalectomy; Aged; Antibodies; Breast Neoplasms; Cross Reactions; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Postmenopause; Prospective Studies; Radioimmunoassay | 1994 |
Fibroid growth in response to high-dose progestogen.
Topics: Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Megestrol; Megestrol Acetate; Middle Aged; Progestins; Tamoxifen; Ultrasonography; Uterine Neoplasms | 1995 |
Transvaginal sonography in a woman treated with megestrol acetate for breast cancer.
Topics: Atrophy; Breast Neoplasms; Dilatation and Curettage; Endometrium; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Ultrasonography; Uterine Hemorrhage | 1994 |
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1994 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Humans; Megestrol; Norpregnadienes; Pregnenediones; Progesterone Congeners; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured | 1994 |
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Dactinomycin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.
Topics: Breast Neoplasms; Female; Humans; Hydroxysteroid Dehydrogenases; Megestrol; Norpregnadienes; Sulfatases; Tumor Cells, Cultured | 1996 |
Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Cycle; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Megestrol; Norpregnadienes; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2001 |
Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: a model for Europe and Australia.
Topics: Aged; Algorithms; Androstadienes; Antineoplastic Agents, Hormonal; Australia; Breast Neoplasms; Cost-Benefit Analysis; Europe; Female; Humans; Megestrol; Middle Aged; Models, Economic | 2002 |
[Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
Topics: Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Immunohistochemistry; Inhibitory Concentration 50; Isoenzymes; Megestrol; Multidrug Resistance-Associated Proteins; Norpregnadienes; Progesterone Congeners; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Verapamil | 2002 |
Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
Topics: Animals; Breast Neoplasms; Cats; Chlormadinone Acetate; Contraceptive Agents, Female; Disease Models, Animal; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Estrogens; Female; Gonadotropins, Pituitary; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Megestrol; Neoplasms; Progesterone; Swine | 1976 |
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy.
Topics: Adult; Aged; Bone Marrow; Breast Neoplasms; Drug Resistance; Drug Therapy, Combination; Female; Humans; Megestrol; Middle Aged; Mitomycins; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1978 |
Further clinical studies with megestrol acetate in advanced breast cancer.
Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Male; Megestrol; Menopause; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1976 |
Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Adult; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Megestrol; Menopause, Premature; Polyps; Tamoxifen | 1992 |
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
Overprolonged adjuvant tamoxifen therapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Megestrol; Survival Rate; Tamoxifen | 1991 |
A pilot study of stanozolol for advanced breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen | 1991 |
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen | 1991 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
Treatment of cancer anorexia with megestrol acetate: impact on quality of life.
Topics: Anorexia; Appetite; Breast Neoplasms; Eating; Feeding and Eating Disorders; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Psychological Tests; Quality of Life; Weight Loss | 1990 |
Determination of megestrol acetate and cyproterone acetate in serum of patients with advanced breast cancer by high-performance liquid chromatography.
Topics: Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Cyproterone; Cyproterone Acetate; Gas Chromatography-Mass Spectrometry; Humans; Megestrol; Megestrol Acetate | 1990 |
Complete remission of a brain metastasis to third-line hormonal treatment with megestrol acetate.
Topics: Brain Neoplasms; Breast Neoplasms; Carbamazepine; Carcinoma, Intraductal, Noninfiltrating; Dexamethasone; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Ovariectomy; Remission Induction | 1990 |
Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aminoglutethimide; Breast Neoplasms; Drug Interactions; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Progestins | 1990 |
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings.
Topics: Aged; Androgens; Breast Neoplasms; Estrogens; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin; Transcortin | 1990 |
[Palliative treatment of skeletal metastases in patients with breast carcinoma].
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Megestrol; Neoplasm Metastasis; Palliative Care | 1987 |
Oral high-dose progestins as treatment for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies | 1989 |
Megestrol acetate in breast cancer--a panel discussion.
Topics: Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Megestrol; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Ocular toxicity of tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorescein Angiography; Head and Neck Neoplasms; Humans; Megestrol; Middle Aged; Retinal Diseases; Tamoxifen; Visual Acuity | 1989 |
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Management of patients with advanced breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Megestrol | 1989 |
Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Breast Neoplasms; Cholestasis, Intrahepatic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Jaundice; Mastectomy, Radical; Megestrol; Megestrol Acetate; Methotrexate; Prednisone; Vincristine | 1989 |
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged | 1986 |
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin | 1986 |
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay | 1988 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Tamoxifen; Viscera | 1988 |
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Retrospective Studies; Tamoxifen | 1988 |
Megestrol acetate as primary hormonal therapy for advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 1988 |
Sequential hormone therapy for advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Soft Tissue Neoplasms; Tamoxifen | 1988 |
High-dose megestrol acetate in the treatment of advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis | 1988 |
Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catecholamines; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Nutritional Status; Pyridoxine; Steroids; Tamoxifen; Trace Elements | 1987 |
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
Topics: Aged; Appetite; Body Weight; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged | 1987 |
Management of hormone responsive diseases. Proceedings of the third international conference. June 7, 1986, Rotterdam, The Netherlands.
Topics: Breast Neoplasms; Female; Hormones; Humans; Megestrol; Megestrol Acetate; Neoplasms | 1986 |
High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasms, Hormone-Dependent | 1986 |
Megestrol acetate: first-line therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Retrospective Studies; Tamoxifen | 1986 |
Appetite stimulation with megestrol acetate in cachectic cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appetite; Body Weight; Breast Neoplasms; Cachexia; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Regression Analysis | 1986 |
High-dose megestrol acetate. A possible treatment for cachexia.
Topics: Body Weight; Breast Neoplasms; Cachexia; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged | 1987 |
Megestrol acetate therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Carcinoma; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Tamoxifen; Time Factors | 1986 |
Mechanisms of action of progestational agents.
Topics: Breast Neoplasms; Cell Count; Cells, Cultured; Female; Humans; Megestrol; Megestrol Acetate; Progesterone; Progestins | 1985 |
Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Patient Compliance; Receptors, Estrogen | 1985 |
Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
Topics: Aged; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen | 1985 |
A clinical trial of megestrol acetate in advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Megestrol; Middle Aged; Remission, Spontaneous; Time Factors | 1974 |